Mariner
LFST icon

Mariner’s Lifestance Health LFST Stock Holding History

Mariner’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$331K Buy
51,907
+26,727
+106% +$186K ﹤0.01% 2784
2025
Q4 		$178K Buy
25,180
+4,919
+24% +$29.7K ﹤0.01% 3200
2025
Q3 		$111K Buy
+20,261
New +$99.3K ﹤0.01% 3336

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SPIG
Silversmith Partners I GP Boston, Massachusetts $39.2M AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Mariner's LFST Position: Q1 2026 in Review

Mariner increased its Lifestance Health (LFST) stake by 106% in Q1 2026, buying an estimated $186K and bringing the position to 51,907 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #2784.

Mariner first reported a position in LFST in Q3 2025 and has held it in 3 quarters since. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Mariner held 51,907 shares of Lifestance Health worth $331K as of Q1 2026.
  • Mariner bought 26,727 Lifestance Health shares in Q1 2026, an estimated $186K.
  • Lifestance Health made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #2784 holding.
  • Mariner first reported a position in Lifestance Health in Q3 2025 and has held it in 3 quarters since.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.